Cargando…

Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHD

Objective: To assess relationships between treatment-associated changes in measures of ADHD symptoms, functional impairments, and health-related quality of life in children and adolescents with ADHD. Method: Pearson correlation coefficients were calculated post hoc for changes from baseline to endpo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coghill, David R., Joseph, Alain, Sikirica, Vanja, Kosinski, Mark, Bliss, Caleb, Huss, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732817/ https://www.ncbi.nlm.nih.gov/pubmed/28836895 http://dx.doi.org/10.1177/1087054717723984

Ejemplares similares

Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses
por: Coghill, David R., et al.
Publicado: (2020)

Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder
por: Gajria, Kavita, et al.
Publicado: (2015)

Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
por: Fridman, Moshe, et al.
Publicado: (2017)

Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe
por: Fridman, Moshe, et al.
Publicado: (2017)

Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
por: Flood, Emuella, et al.
Publicado: (2016)

Developing the Symptoms and Functional Impairment Rating Scale: A Multi-Dimensional ADHD Scale
por: Du, Yasong, et al.
Publicado: (2018)

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
por: Huss, Michael, et al.
Publicado: (2016)

Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case
por: Le, Hoa H., et al.
Publicado: (2013)

Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison
por: Joseph, Alain, et al.
Publicado: (2017)

Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
por: Lachaine, Jean, et al.
Publicado: (2016)

Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate
por: Nagy, Peter, et al.
Publicado: (2015)

Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate
por: Coghill, David R., et al.
Publicado: (2018)

Services for adults with ADHD: work in progress(†): Commentary on . . . Specialist adult ADHD clinics in East Anglia
por: Coghill, David
Publicado: (2015)

Relationship between subtypes and symptoms of ADHD, insomnia, and nightmares in connection with quality of life in children
por: Grünwald, Julia, et al.
Publicado: (2017)

ADHD symptoms and school impairment history in parents of ADHD children are a fundamental diagnostic and therapeutic clue
por: Wiel, Luisa Cortellazzo, et al.
Publicado: (2022)

Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study
por: Sikirica, Vanja, et al.
Publicado: (2017)

ADHD symptoms and their neurodevelopmental correlates in children born very preterm
por: Montagna, Anita, et al.
Publicado: (2020)

The Impact of Childhood Attention-Deficit/Hyperactivity Disorder (ADHD) on Children’s Health-Related Quality of Life: A Systematic Review and Meta-Analysis
por: Wanni Arachchige Dona, Sithara, et al.
Publicado: (2023)

Relationship between Bullying Victimization and Quality of Life in Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) in Taiwan: Mediation of the Effects of Emotional Problems and ADHD and Oppositional Defiant Symptoms
por: Lin, Chien-Wen, et al.
Publicado: (2021)

The Impact of Depressive Symptoms in Adults with ADHD Symptoms on Family Function and ADHD Symptoms of Their Children
por: Hong, Soon-Beom, et al.
Publicado: (2014)

Exploring ADHD Symptoms and Associated Impairment Across Development
por: Niina, Ayako, et al.
Publicado: (2022)

3Avoiding the 'twilight zone': recommendations for the transition of services from adolescence to adulthood for young people with ADHD
por: Young, Susan, et al.
Publicado: (2011)

Concomitant Pharmacotherapy of Psychotropic Medications in EU Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Sikirica, Vanja, et al.
Publicado: (2013)

Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway
por: Coghill, David, et al.
Publicado: (2015)

Are Anxiety Disorders in Children and Adolescents Less Impairing Than ADHD and Autism Spectrum Disorders? Associations with Child Quality of Life and Parental Stress and Psychopathology
por: Telman, Liesbeth G. E., et al.
Publicado: (2017)

An observational study of once-daily modified-release methylphenidate in ADHD: the effect of previous treatment on ADHD symptoms, other externalising symptoms and quality-of-life outcomes
por: Döpfner, Manfred, et al.
Publicado: (2011)

Quality of Life in Caregivers of ADHD Children and Diabetes Patients
por: Andrade, Elisa Meirelles, et al.
Publicado: (2016)

Mother's and children's ADHD genetic risk, household chaos and children's ADHD symptoms: A gene–environment correlation study
por: Agnew‐Blais, Jessica C., et al.
Publicado: (2022)

The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)
por: Coghill, David, et al.
Publicado: (2021)

The impact of ADHD on the health and well-being of ADHD children and their siblings
por: Peasgood, Tessa, et al.
Publicado: (2016)

The Impact of Internalizing Symptoms on Impairment for Children With ADHD: A Strength-Based Perspective
por: Bethune, Sarah C., et al.
Publicado: (2022)

Video Games in ADHD and Non-ADHD Children: Modalities of Use and Association With ADHD Symptoms
por: Masi, Laura, et al.
Publicado: (2021)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
por: Joseph, Alain, et al.
Publicado: (2016)

The associations between ADHD, pain, inflammation, and quality of life in children and adolescents—a clinical study protocol
por: Kerekes, Nóra, et al.
Publicado: (2022)

Health-related quality of life and perceived stress of informal caregivers of children and adolescents with intellectual disabilities and ADHD
por: Dubey, M.J., et al.
Publicado: (2023)

Shared Cognitive Impairments and Aetiology in ADHD Symptoms and Reading Difficulties
por: Cheung, Celeste H. M., et al.
Publicado: (2014)

Young Adult ADHD Symptoms in the General Population and Neurocognitive Impairment
por: Agha, Sharifah Shameem, et al.
Publicado: (2023)

The efficacy of physical exercise interventions on mental health, cognitive function, and ADHD symptoms in children and adolescents with ADHD: an umbrella review
por: Dastamooz, Sima, et al.
Publicado: (2023)

The role of stress coping strategies for life impairments in ADHD
por: Barra, Steffen, et al.
Publicado: (2021)

Starting ADHD medications during the COVID-19 pandemic: recommendations from the European ADHD Guidelines Group
por: Cortese, Samuele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0nnb4i8a89obmo9r0grk2qhcom